Research Library

Women living with HIV in the Middle East face public scrutiny, stigmatization and even abandonment. It is critical not only to curb the spread of HIV in the region, but also to educate and protect women who may be less knowledgeable about the disease, writes Ariana Marnicio, research analyst for the Women and Human Rights in the Middle East Program.

Peter Hotez, fellow in disease and poverty, proposes ways for countries around the world to increase their reliance on vaccine diplomacy in their foreign policy approaches.

By Jerry Epstein

Following the legalization of retail marijuana sales in Colorado and Washington, and medical marijuana…

In this article, Peter Hotez, fellow in disease and poverty, summarizes 10 of the worst global “hotspots” where neglected tropical diseases predominate.

More than one-third of Texas’ six million uninsured residents are “Young Invincibles,” and their participation in the Marketplace is critical to reduce the uninsured rate among all Texans. While these young adults have substantial need for health coverage, on the eve of the launch of the Marketplace, Texas’ “Young Invincibles” had a poor understanding of the Affordable Care Act’s health coverage opportunities and held a low opinion of the new law.

Although Aboriginal people make up a small percentage of the world's population, they are disproportionately affected by poverty and neglected tropical diseases.

Many contemporary medical ethicists dismiss the centuries-old Hippocratic Oath as outdated because of the enormous scientific, social, economic, and political changes since Hippocrates' time. Health policy scholar Hagop Kantarjian makes a case for its relevance.

Neglected tropical diseases are a significant public health problem in some parts of the southern U.S., including Texas, says Peter Hotez, fellow in disease and poverty.

Every patient with cancer or another life-threatening disease wants the most effective treatment, but drug prices have become staggering. What determines the escalating prices of cancer drugs?

Allowing the producer-dominated market to set drug prices has spiraled the cost of cancer drugs out of control. Drug pricing can be reduced while preserving the profit-making incentive, by linking price to a true measure of quality: preservation and meaningful prolongation of life.